Global biopharmaceutical company Bristol Myers Squibb (BMS) has appointed Pamela Fisher as its Chief Diversity and Inclusion Officer.

Fisher’s new role sits in the BMS leadership team led by its CEO Giovanni Caforio. There, she will steer its Global Diversity & Inclusion (D&I) business strategy and advance its ‘five core diversity commitments.’ This has recently had its first anniversary and includes workforce representation, health equity, supplier diversity, clinical trial diversity, and employee giving.

Fisher will promote BMS’s eight People & Business Resource Groups (PBRGs) as part of her role. They are open to the global workforce and include Black Organization for Leadership and Development (BOLD), Bristol Myers Squibb Network of Women (B-NOW), Cultivating Leadership and Innovation for Millennials and Beyond (CLIMB) and more. She will also help advance the firm’s Global Diversity Inclusion Council.

Fisher’s appointment follows the publication of BMS’s first Global Diversity and Inclusion Report, which outlines its progress in addressing its five diversity commitments.

Fisher brings over twenty years of experience in diversity and inclusion to her new role and experience in global strategy, partnerships, philanthropy, government relations, and business growth.

Before BMS, she was at Johnson & Johnson. She served as Head of Diversity, Equity & Inclusion Global Strategy and Partnerships and launched an evidence-based D&I strategy that helped grow the business by reaching diverse and multi-cultural patients and consumers.

In her past role at Johnson & Johnson, Fisher also worked to increase diverse workforce representation and improve workforce engagement and sentiment on inclusion.

Caforio said: “As a science leader, we have seen first-hand how diversity of thought, experience, and background drives innovation that transforms patients’ lives. Pam is joining our company as we make progress on our commitment to increase health equity, further strengthen our diversity and shape our culture of inclusion.”